There are increasing reports of therapies wherein blockade of PD-1 or PD-L1 exhibits anti-tumor efficacy dependent upon or involving TAMs repolarization [15, 16, 25, 26, 29–31]. This evidence concerns the gene CD274 and neoplasm.